Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUCELL CORP /DE/ Director's Dealing 2009

Mar 18, 2009

34519_dirs_2009-03-18_411eaba6-7c7f-4285-a66f-81dcfd46310d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2009-03-16

Reporting Person: ROTHSCHILD JONATHAN E (Director, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2009-03-16 Common stock, par value $0.10 per share P 400 $1.81 Acquired 439702 Direct
2009-03-17 Common stock, par value $0.10 per share P 100 $1.91 Acquired 439802 Direct
2009-03-17 Common stock, par value $0.10 per share P 200 $1.91 Acquired 440002 Direct

Footnotes

F1: These shares were acquired by Arterio, Inc., a company solely owned by Mr. Rothschild.

F2: This figure includes 185,173 shares of common stock held by Arterio, Inc., a corporation owned solely by Mr. Rothschild.